Firms
Theme

APP

Applovin Corporation Class A · NASDAQ

↓ $4.03 (1.52%)

Last close · Oct 23, 4:00 PM ET

Sign up free to see this.

Mkt Cap
$87.1B
Volume
2M
52W High
$738.01
52W Low
$258.32
PE Ratio
19.7
Avg Vol
4.8M
As of 10/23/26
Div Yield
—
Beta
2.27
As of 10/23/26

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Sentiment

No sentiment yet

At least 5 tagged posts are needed.

How do you feel about APP?

Latest news

News ›

GlobeNewswire Inc.

ROSEN, SKILLED INVESTOR COUNSEL, Encourages AppLovin Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – APP

Rosen Law Firm is notifying investors in AppLovin Corporation, Beta Bionics, Inc., and Netcapital Inc. about ongoing securities class action lawsuits. AppLovin investors who purchased shares between February 12, 2026 and August 5, 2026 must act by November 16, 2026 deadline. The lawsuit alleges AppLovin made false statements about AI video features, overstated AI model improvements, and misrepresented the benefits of its AI platform's 'virtuous cycle' value proposition.

Zacks Investment Research

AppLovin (APP) Beats Stock Market Upswing: What Investors Need to Know

AppLovin (APP) outperformed the broader market on October 19, 2026, gaining 1.05% to close at $268.92, ahead of the S&P 500's 0.41% gain. The company is expected to report earnings on November 4, 2026, with forecasted EPS of $3.95 (up 61.22% YoY) and revenue of $2.08 billion (up 47.78% YoY). However, AppLovin holds a Zacks Rank #4 (Sell) rating and trades at a premium valuation with a Forward P/E of 16.98 versus the industry average of 15.84.

Zacks Investment Research

AppLovin Corporation (APP) is Attracting Investor Attention: Here is What You Should Know

AppLovin (APP) has attracted investor attention despite a -13.6% decline over the past month, outpacing the Technology Services industry's -8.1% loss. While the company shows strong fundamentals with expected earnings growth of +56.1% for the current fiscal year and revenue growth of +39.1%, the Zacks Rank #4 (Sell) rating suggests the stock may underperform the broader market in the near term. The company's valuation is rated C, indicating it trades at par with peers.

Headlines link to the publisher. Not investment advice.

Board · 0 threads

Open board ›

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $APP · 0 threads

Sign in to post on $APP

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev